Agenda

Please note all sessions listed in Eastern Time. Agenda and credit amount subject to change.

Download Agenda

DAY 1 | FRIDAY, OCTOBER 23

6:30 am

—

Registration

Registration

7:00 am

—

8:15 am

Breakfast & Non-CME/CE Bonus Presentation

Learn About a Treatment for Agitation Associated with Dementia Due to Alzheimer's Disease

Learn About a Treatment for Agitation Associated with Dementia Due to Alzheimer's Disease

Speaker: Marc Agronin, MD

Sponsored by Axsome Therapeutics

8:15 am

—

8:30 am

Exhibit Hall Opens

Exhibit Hall Opens

8:30 am

—

8:35 am

Conference Welcome

Conference Welcome

Henry A. Nasrallah, MD

8:35 am

—

9:20 am

The Psychopharmacology of Difficult-to-Treat Alcohol and Substance Use Disorders

The Psychopharmacology of Difficult-to-Treat Alcohol and Substance Use Disorders

Mark S. Gold, MD

9:20 am

—

9:35 am

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Mark S. Gold, MD

9:40 am

—

10:55 am

Refreshments & Non-CME/CE Bonus Presentation

When Antidepressants Aren’t Enough: Understanding Unmet Needs as Drivers of Treatment Strategy

When Antidepressants Aren’t Enough: Understanding Unmet Needs as Drivers of Treatment Strategy

Speaker: Niku Singh, MD

Sponsored by Johnson & Johnson

10:55 am

—

11:25 am

Break: Visit Exhibit Hall

Break: Visit Exhibit Hall

11:25 am

—

12:10 pm

An Update on Managing Eating Disorders

An Update on Managing Eating Disorders

Heather A. Dlugosz, MD, FAPA, CEDS; Elizabeth Wassenaar, MD, DFAPA, CEDS-S

12:10 pm

—

12:25 pm

Audience Q&A

Audience Q&A

Danielle Johnson, MD; Heather A. Dlugosz, MD, FAPA, CEDS; Elizabeth Wassenaar, MD, DFAPA, CEDS-S

‍

12:25 pm

—

1:40 pm

Lunch & Non-CME/CE Bonus Presentation

Understanding the Impact of Tardive Dyskinesia: Exploring a Patient’s Perspective

Understanding the Impact of Tardive Dyskinesia: Exploring a Patient’s Perspective

Speaker: Rebecca Roma, MD

Sponsored by Neurocrine Biosciences

1:40 pm

—

1:55 pm

Refreshment Break: Visit Exhibit Hall

Refreshment Break: Visit Exhibit Hall

1:55 pm

—

2:55 pm

Independent CME Symposium

Independent CME Symposium

3:00 pm

—

3:45 pm

An Update on the Pharmacotherapy of Difficult-to-Treat Personality Disorders

An Update on the Pharmacotherapy of Difficult-to-Treat Personality Disorders

Donald W. Black, MD

3:45 pm

—

4:00 pm

Audience Q&A

Audience Q&A

Danielle Johnson, MD; Donald W. Black, MD

‍

4:00 pm

—

4:45 pm

An Update on Managing Difficult-to-Treat Autism, OCD and Impulse Control Disorders

An Update on Managing Difficult-to-Treat Autism, OCD and Impulse Control Disorders

Eric Hollander, MD

4:45 pm

—

5:00 pm

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Eric Hollander, MD

5:00 pm

—

5:15 pm

Break: Visit Exhibit Hall

Break: Visit Exhibit Hall

5:15 pm

—

6:00 pm

Keynote: Technological Addictions: From Internet Gaming and Cybersex to Social Media and Digital Hyperconnectivity

Keynote: Technological Addictions: From Internet Gaming and Cybersex to Social Media and Digital Hyperconnectivity

Petros Levounis, MD, MA

6:00 pm

—

6:15 pm

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Petros Levounis, MD, MA

6:15 pm

—

7:15 pm

Dinner with Dr. Henry A. Nasrallah & Non-CME/CE Bonus Presentation

Dinner with Dr. Henry A. Nasrallah & Non-CME/CE Bonus Presentation

7:15 pm

—

Day One Adjourns

Day One Adjourns

DAY 2 | SATURDAY, OCTOBER 24

6:45 am

—

Registration

Registration

7:00 am

—

8:00 am

Breakfast & Non-CME/CE Bonus Presentation

Breakfast & Non-CME/CE Bonus Presentation

8:00 am

—

8:15 am

Exhibit Hall Opens

Exhibit Hall Opens

8:15 am

—

8:20 am

Morning Welcome

Morning Welcome

Henry A. Nasrallah, MD

8:20 am

—

9:05 am

Update on Managing Difficult-to-Treat Anxiety Disorders Across the Life Cycle

Update on Managing Difficult-to-Treat Anxiety Disorders Across the Life Cycle

Jeffrey R. Strawn, MD

9:05 am

—

9:20 am

Audience Q&A

Audience Q&A

Danielle Johnson, MD; Jeffrey R. Strawn, MD

9:25 am

—

10:25 am

Refreshments & Non-CME/CE Bonus Presentation

Expanding Our Perspectives: Discover a Unique Treatment Option for Adults with Schizophrenia

Expanding Our Perspectives: Discover a Unique Treatment Option for Adults with Schizophrenia

Speaker: Parinda Parikh, MD

Sponsored by Bristol Myers Squibb

10:25 am

—

10:55 am

Break: Visit Exhibit Hall

Break: Visit Exhibit Hall

10:55 am

—

11:40 am

An Update on Managing Difficult-to-Treat Mood Disorders

An Update on Managing Difficult-to-Treat Mood Disorders

Stephen Rush, MD

11:40 am

—

11:55 am

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Stephen Rush, MD

11:55 am

—

1:10 pm

Lunch & Non-CME/CE Bonus Presentation

An Established Treatment Option for Managing Bipolar I Disorder or Schizophrenia

An Established Treatment Option for Managing Bipolar I Disorder or Schizophrenia

Speaker: Joseph F. Goldberg, MD

Sponsored by Alkermes, Inc.

1:10 pm

—

1:25 pm

Refreshment Break: Visit Exhibit Hall

Refreshment Break: Visit Exhibit Hall

1:25 pm

—

2:10 pm

Update on Managing Difficult-to-Treat Psychosis Spectrum Disorders

Update on Managing Difficult-to-Treat Psychosis Spectrum Disorders

Leslie Citrome, MD, MPH

2:10 pm

—

2:25 pm

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Leslie Citrome, MD, MPH

2:25 pm

—

3:10 pm

Update on Managing Difficult-to-Treat ADHD

Update on Managing Difficult-to-Treat ADHD

David W. Goodman, MD, LFAPA

3:10 pm

—

3:25 pm

Audience Q&A

Audience Q&A

Danielle Johnson, MD; David W. Goodman, MD, LFAPA

3:25 pm

—

4:10 pm

Psychopharmacology Implications of Shared Genetics and Neurobiology Across Multiple Psychiatric Disorders

Psychopharmacology Implications of Shared Genetics and Neurobiology Across Multiple Psychiatric Disorders

Henry A. Nasrallah, MD

4:10 pm

—

4:25 pm

Audience Q&A

Audience Q&A

Danielle Johnson, MD; Henry A. Nasrallah, MD

4:25 pm

—

4:30 pm

Closing Remarks

Closing Remarks

4:30 pm

—

Conference Adjourns

Conference Adjourns

DAY 1 | FRIDAY, OCTOBER 23

6:30 am

—

Registration

Registration

7:00 am

—

8:15 am

Breakfast & Non-CME/CE Bonus Presentation

Learn About a Treatment for Agitation Associated with Dementia Due to Alzheimer's Disease

Learn About a Treatment for Agitation Associated with Dementia Due to Alzheimer's Disease

Speaker: Marc Agronin, MD

Sponsored by Axsome Therapeutics

8:15 am

—

8:30 am

Exhibit Hall Opens

Exhibit Hall Opens

8:30 am

—

8:35 am

Conference Welcome

Conference Welcome

Henry A. Nasrallah, MD

8:35 am

—

9:20 am

The Psychopharmacology of Difficult-to-Treat Alcohol and Substance Use Disorders

The Psychopharmacology of Difficult-to-Treat Alcohol and Substance Use Disorders

Mark S. Gold, MD

9:20 am

—

9:35 am

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Mark S. Gold, MD

9:40 am

—

10:55 am

Refreshments & Non-CME/CE Bonus Presentation

When Antidepressants Aren’t Enough: Understanding Unmet Needs as Drivers of Treatment Strategy

When Antidepressants Aren’t Enough: Understanding Unmet Needs as Drivers of Treatment Strategy

Speaker: Niku Singh, MD

Sponsored by Johnson & Johnson

10:55 am

—

11:25 am

Break: Visit Exhibit Hall

Break: Visit Exhibit Hall

11:25 am

—

12:10 pm

An Update on Managing Eating Disorders

An Update on Managing Eating Disorders

Heather A. Dlugosz, MD, FAPA, CEDS; Elizabeth Wassenaar, MD, DFAPA, CEDS-S

12:10 pm

—

12:25 pm

Audience Q&A

Audience Q&A

Danielle Johnson, MD; Heather A. Dlugosz, MD, FAPA, CEDS; Elizabeth Wassenaar, MD, DFAPA, CEDS-S

‍

12:25 pm

—

1:40 pm

Lunch & Non-CME/CE Bonus Presentation

Understanding the Impact of Tardive Dyskinesia: Exploring a Patient’s Perspective

Understanding the Impact of Tardive Dyskinesia: Exploring a Patient’s Perspective

Speaker: Rebecca Roma, MD

Sponsored by Neurocrine Biosciences

1:40 pm

—

1:55 pm

Refreshment Break: Visit Exhibit Hall

Refreshment Break: Visit Exhibit Hall

1:55 pm

—

2:55 pm

Independent CME Symposium

Independent CME Symposium

3:00 pm

—

3:45 pm

An Update on the Pharmacotherapy of Difficult-to-Treat Personality Disorders

An Update on the Pharmacotherapy of Difficult-to-Treat Personality Disorders

Donald W. Black, MD

3:45 pm

—

4:00 pm

Audience Q&A

Audience Q&A

Danielle Johnson, MD; Donald W. Black, MD

‍

4:00 pm

—

4:45 pm

An Update on Managing Difficult-to-Treat Autism, OCD and Impulse Control Disorders

An Update on Managing Difficult-to-Treat Autism, OCD and Impulse Control Disorders

Eric Hollander, MD

4:45 pm

—

5:00 pm

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Eric Hollander, MD

5:00 pm

—

5:15 pm

Break: Visit Exhibit Hall

Break: Visit Exhibit Hall

5:15 pm

—

6:00 pm

Keynote: Technological Addictions: From Internet Gaming and Cybersex to Social Media and Digital Hyperconnectivity

Keynote: Technological Addictions: From Internet Gaming and Cybersex to Social Media and Digital Hyperconnectivity

Petros Levounis, MD, MA

6:00 pm

—

6:15 pm

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Petros Levounis, MD, MA

6:15 pm

—

7:15 pm

Dinner with Dr. Henry A. Nasrallah & Non-CME/CE Bonus Presentation

Dinner with Dr. Henry A. Nasrallah & Non-CME/CE Bonus Presentation

7:15 pm

—

Day One Adjourns

Day One Adjourns

DAY 2 | SATURDAY, OCTOBER 24

6:45 am

—

Registration

Registration

7:00 am

—

8:00 am

Breakfast & Non-CME/CE Bonus Presentation

Breakfast & Non-CME/CE Bonus Presentation

8:00 am

—

8:15 am

Exhibit Hall Opens

Exhibit Hall Opens

8:15 am

—

8:20 am

Morning Welcome

Morning Welcome

Henry A. Nasrallah, MD

8:20 am

—

9:05 am

Update on Managing Difficult-to-Treat Anxiety Disorders Across the Life Cycle

Update on Managing Difficult-to-Treat Anxiety Disorders Across the Life Cycle

Jeffrey R. Strawn, MD

9:05 am

—

9:20 am

Audience Q&A

Audience Q&A

Danielle Johnson, MD; Jeffrey R. Strawn, MD

9:25 am

—

10:25 am

Refreshments & Non-CME/CE Bonus Presentation

Expanding Our Perspectives: Discover a Unique Treatment Option for Adults with Schizophrenia

Expanding Our Perspectives: Discover a Unique Treatment Option for Adults with Schizophrenia

Speaker: Parinda Parikh, MD

Sponsored by Bristol Myers Squibb

10:25 am

—

10:55 am

Break: Visit Exhibit Hall

Break: Visit Exhibit Hall

10:55 am

—

11:40 am

An Update on Managing Difficult-to-Treat Mood Disorders

An Update on Managing Difficult-to-Treat Mood Disorders

Stephen Rush, MD

11:40 am

—

11:55 am

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Stephen Rush, MD

11:55 am

—

1:10 pm

Lunch & Non-CME/CE Bonus Presentation

An Established Treatment Option for Managing Bipolar I Disorder or Schizophrenia

An Established Treatment Option for Managing Bipolar I Disorder or Schizophrenia

Speaker: Joseph F. Goldberg, MD

Sponsored by Alkermes, Inc.

1:10 pm

—

1:25 pm

Refreshment Break: Visit Exhibit Hall

Refreshment Break: Visit Exhibit Hall

1:25 pm

—

2:10 pm

Update on Managing Difficult-to-Treat Psychosis Spectrum Disorders

Update on Managing Difficult-to-Treat Psychosis Spectrum Disorders

Leslie Citrome, MD, MPH

2:10 pm

—

2:25 pm

Audience Q&A

Audience Q&A

Henry A. Nasrallah, MD; Leslie Citrome, MD, MPH

2:25 pm

—

3:10 pm

Update on Managing Difficult-to-Treat ADHD

Update on Managing Difficult-to-Treat ADHD

David W. Goodman, MD, LFAPA

3:10 pm

—

3:25 pm

Audience Q&A

Audience Q&A

Danielle Johnson, MD; David W. Goodman, MD, LFAPA

3:25 pm

—

4:10 pm

Psychopharmacology Implications of Shared Genetics and Neurobiology Across Multiple Psychiatric Disorders

Psychopharmacology Implications of Shared Genetics and Neurobiology Across Multiple Psychiatric Disorders

Henry A. Nasrallah, MD

4:10 pm

—

4:25 pm

Audience Q&A

Audience Q&A

Danielle Johnson, MD; Henry A. Nasrallah, MD

4:25 pm

—

4:30 pm

Closing Remarks

Closing Remarks

4:30 pm

—

Conference Adjourns

Conference Adjourns